Established in 2025, Beijing Zhuozhi Medical Technology Co., Ltd. is dedicated to the objective quantitative evaluation and research and development (R&D) of pain diagnosis and treatment solutions. The company recently declared the successful closure of an angel round of financing amounting to 20 million yuan. This round was spearheaded by Zhongguancun Capital, with Shanghai Changyao Shengbo also participating as a co-investor. The funds raised will be predominantly allocated towards the R&D enhancement of the core technology platform and the execution of multi-center clinical studies.

Guided by the principle of 'measurable and controllable,' Zhuozhi Medical has developed a comprehensive closed-loop pain management system. It has also established a core technology platform that integrates specialized EEG and signal acquisition hardware, non-invasive spinal cord stimulation devices, decoding algorithms, and application software.

The company's team comprises seasoned entrepreneurs and renowned scientists. Founder Gao Fei brings a wealth of experience in the life sciences sector, while co-founder Jiang Changyu possesses profound knowledge in neuroscience and pain medicine. The investors have expressed confidence in Zhuozhi Medical's technological advancements, team capabilities, and market potential.